TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investor Securities Class Action Lawsuit 11/18/2021

  • If you purchased a significant amount of shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) between May 11, 2021 and October 5, 2021, and / or if you purchased any NYSE: DNA shares prior to May 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 17, 2022. NYSE: DNA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

November 18, 2021 - An investor in shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. in connection with certain allegedly false and misleading statements made between May 11, 202...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)